Blackstone Life Sciences — 2016 Investments

1 investments dated 2016 · listed companies and verified rows first · show all

Modernamodernatx.com in 𝕏Aug 2016

Moderna develops mRNA-based medicines for infectious and serious diseases using its proprietary mRNA platform and design technology.

BiotechDeep TechMedical DevicesCambridge, US

Robert Langer(Director)Lorence Kim(Executive Officer)James R. Kasinger(Executive Officer)Stephen Hoge(Executive Officer)

BoardStephane Bancel(Executive Officer, Director)John Mendlein(Director)

Co-investorsAglae Ventures Flagship Pioneering FPV Khosla Ventures Premji Invest RA Capital

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.